Heart Health with UnityPoint Health | Des Moines, Iowa
Your heart deserves the very best care, with top quality, safety and a high level of customer service. UnityPoint Health – Des Moines Cardiology locations provide state-of-the-art technology in a comfortable setting with knowledgeable and compassionate team members. Our providers have board-certifications in cardiac sub-specialties. They're able to coordinate virtually everything you need; tests, surgeries, advanced clinical procedures and rehabilitation to keep your heart healthy and strong.
Complete diagnostic and interventional cardiac catheterization laboratory services offer advanced capabilities for hospital inpatients.
Cardiac rehabilitation services at Iowa Lutheran, Iowa Methodist, and Methodist West are designed to help patients return to their optimum level of health. The cardiac rehabilitation staff works along side physicians to help patients with heart disease recover faster and feel better.
Learn more about the technology offered in our cardiology locations.
Absorb, the only fully dissolving heart stent
Introducing Absorb, the only heart stent that full dissolves. It is made of the same material used in medical stitches. And it restores blood flow to your artery - then goes away naturally - leaving nothing permanent behind.
Absorb is used in more than 100 countries and has treated more than 150,000 patients. The first person who received Absorb was treated in New Zealand more than 10 years ago. It is now FDA approved and available in the U.S.
Iowa Methodist at UnityPoint Health - Des Moines is the second hospital in the State of Iowa and the only UnityPoint Health facility to have this new technology available for patient care and treatment of arterial stenosis of the coronary arteries.
For additional information, contact your cardiologist.
CardioMEMSTM Heart Failure Monitoring
Iowa Lutheran Hospital is the first Iowa hospital to offer a new heart failure treatment: the CardioMEMS™ HF System. This treatment is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure.
The new heart failure treatment includes a sensor that is implanted in the pulmonary artery (PA) during a non-surgical procedure to directly measure PA pressure. Increased PA pressures appear before weight and blood pressure changes, which are often used as indirect measures of worsening heart failure. This new treatment allows patients to transmit daily sensor readings from their homes to their health care providers allowing for personalized and proactive management to reduce the likelihood of hospitalization.
How Does It Work?
The implantable sensor is a completely sealed capsule that uses microelectromechanical systems (MEMS) technology, which allows the creation of sensors with measurement stability and energy efficiency. All of the sensor components are made of materials that have been chosen for their durability, robustness, biocompatibility, and insensitivity to changes in body chemistry or biology. This new heart failure treatment is powered by radio frequency (RF) energy. It is implanted into the pulmonary artery using minimally invasive techniques via a catheter and is designed to last the lifetime of the patient.
The sensor does not have a battery or leads and is very small. Once implanted, the sensor wirelessly sends pressure readings to the external patient electronic system. There is no pain or sensation for the patient during the readings. The electronics transmit the readings to a secure website where it can be seen by the patient's clinician. The external measurement system wirelessly tracks frequency and uses it to determine the pressure in the pulmonary artery.
At home, heart failure patients use a portable electronic unit and a special pillow containing an antenna to take daily sensor readings. This is a simple process that takes only a few minutes. The patient's electronic unit is turned on and the patient lies on the pillow. The electronic unit uses audible signals telling the patient to press the button to initiate a reading. The pressure readings are then wirelessly transmitted to a secure website.
Who Is It For?
Historically, heart failure has been one of the most common reasons for hospitalizations in people over 70 years of age. Doctors monitor the weight and blood pressure of heart failure patients and might prescribe several different medications and even recommend a cardiac resynchronization therapy device, or CRT. The CardioMEMS HF System can be used in conjunction with other medical therapies to better understand how a patient's body responds to different therapies, such as medications, lifestyle changes, or CRT
What Are the Patient Benefits?
When used by clinicians to manage heart failure, the CardioMEMS HF System can help heart failure patients better manage their condition and possibly prevent future hospitalizations. The system is:
Safe and reliable. 98.6% of patients were free from device or system complications
Clinically proven. Reduced heart failure admissions by 37%
Proactive and personalized. Patient management through direct monitoring of PA pressure and titration of medications
Reduce risk of heart failure hospital admission and improve quality of life with the CardioMEMS HF System. Call UnityPoint Clinic - Cardiology at (515) 263-2400 to learn if you are a candidate for the non-invasive procedure.
Transcatheter Aortic Valve Replacement (TAVR)
TAVR is a minimally invasive surgical procedure to repair the heart valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place.
Similar to a stent placed in an artery, the TAVR approach delivers a fully collapsible replacement valve to the valve site through a catheter. Once the valve is expanded, it pushed the old valve out of the way out of the way and the tissue in the replacement valve takes over the job regulating blood flow.
How is TAVR different from standard valve replacement?
Usually, valve replacement requires an open heart procedure in which the chest is open for the procedure. The TAVR procedure can be done through very small openings that leave all the chest bones in place.
A TAVR procedure is not without risks, but it provides beneficial treatment options to people who may not have been candidates a few years ago, while also providing the added bonus of a faster recovery in most cases. A patient's experience with a TAVR procedure may be comparable to a balloon treatment or even an angiogram in terms of downtime and recovery, and will likely require a shorter hospital stay (average 3-5 days).
Micra, the world's smallest pacemaker
Unlike most pacemakers that are placed in the patient's chest with leads running to the heart, Micra is implanted directly into the patient's heart.
What is the Micra Pacemaker?